237 related articles for article (PubMed ID: 9988270)
1. Activating SRC mutation in a subset of advanced human colon cancers.
Irby RB; Mao W; Coppola D; Kang J; Loubeau JM; Trudeau W; Karl R; Fujita DJ; Jove R; Yeatman TJ
Nat Genet; 1999 Feb; 21(2):187-90. PubMed ID: 9988270
[TBL] [Abstract][Full Text] [Related]
2. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
Lansing TJ; Turk BF; Kanner SB; Gilmer TM
Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
[TBL] [Abstract][Full Text] [Related]
3. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential.
Irby R; Mao W; Coppola D; Jove R; Gamero A; Cuthbertson D; Fujita DJ; Yeatman TJ
Cell Growth Differ; 1997 Dec; 8(12):1287-95. PubMed ID: 9419417
[TBL] [Abstract][Full Text] [Related]
5. SRC gene expression in human cancer: the role of transcriptional activation.
Dehm SM; Bonham K
Biochem Cell Biol; 2004 Apr; 82(2):263-74. PubMed ID: 15060621
[TBL] [Abstract][Full Text] [Related]
6. Lack of mutation at codon 531 of SRC in advanced colorectal cancers from Italian patients.
Laghi L; Bianchi P; Orbetegli O; Gennari L; Roncalli M; Malesci A
Br J Cancer; 2001 Jan; 84(2):196-8. PubMed ID: 11161376
[TBL] [Abstract][Full Text] [Related]
7. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.
Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE
Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101
[TBL] [Abstract][Full Text] [Related]
8. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.
Staley CA; Parikh NU; Gallick GE
Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668
[TBL] [Abstract][Full Text] [Related]
9. Critical amino acid substitutions in the Src SH3 domain that convert c-Src to be oncogenic.
Miyazaki K; Senga T; Matsuda S; Tanaka M; Machida K; Takenouchi Y; Nimura Y; Hamaguchi M
Biochem Biophys Res Commun; 1999 Oct; 263(3):759-64. PubMed ID: 10512753
[TBL] [Abstract][Full Text] [Related]
10. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
11. Identification of Src transformation fingerprint in human colon cancer.
Malek RL; Irby RB; Guo QM; Lee K; Wong S; He M; Tsai J; Frank B; Liu ET; Quackenbush J; Jove R; Yeatman TJ; Lee NH
Oncogene; 2002 Oct; 21(47):7256-65. PubMed ID: 12370817
[TBL] [Abstract][Full Text] [Related]
12. The road to Src.
Martin GS
Oncogene; 2004 Oct; 23(48):7910-7. PubMed ID: 15489909
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
14. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.
Du Villard JA; Wicker R; Crespo P; Russo D; Filetti S; Gutkind JS; Sarasin A; Suárez HG
Oncogene; 2000 Oct; 19(42):4896-905. PubMed ID: 11039907
[TBL] [Abstract][Full Text] [Related]
15. Regulation of alternative SRC promoter usage in HepG2 hepatocellular carcinoma cells.
Dehm SM; Bonham K
Gene; 2004 Aug; 337():141-50. PubMed ID: 15276210
[TBL] [Abstract][Full Text] [Related]
16. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW
Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013
[TBL] [Abstract][Full Text] [Related]
17. [Expression of the p56lck by colon tumors: a marker of their invasive capacity?].
Rouer E
Bull Cancer; 2004 Dec; 91(12):928-40. PubMed ID: 15634634
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
[TBL] [Abstract][Full Text] [Related]
19. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death.
Lluis JM; Buricchi F; Chiarugi P; Morales A; Fernandez-Checa JC
Cancer Res; 2007 Aug; 67(15):7368-77. PubMed ID: 17671207
[TBL] [Abstract][Full Text] [Related]
20. A novel germ line juxtamembrane Met mutation in human gastric cancer.
Lee JH; Han SU; Cho H; Jennings B; Gerrard B; Dean M; Schmidt L; Zbar B; Vande Woude GF
Oncogene; 2000 Oct; 19(43):4947-53. PubMed ID: 11042681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]